CNTA

Centessa Pharmaceuticals plc

Healthcare›Biotechnology|NASDAQ Global Select|GB

Price

$39.69

Market Cap

$5.34B

Beta

1.55

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+0.00%

EPS Growth (YoY)+26.63%

Revenue CAGR 3Y+0.00%

P/E Ratio0.0

PEG Ratio—

FCF Yield-3.64%

Debt / Equity0.01

Interest Coverage-18.1x

No credit card required

Already have an account? Sign in to view the full analysis for CNTA.